Congress has directed the Department of Defense to reach an “arrangement with the JASON scientific advisory group to conduct national security studies and analyses.”
Last spring DoD officials sought to let the existing contract with the JASONs lapse, leaving the panel without a sponsor and threatening its continued viability. The new legislation rejects that move, although it anticipates that the JASON contract will now be managed instead by the DoD Under Secretary for Acquisition and Sustainment instead of by Defense Research and Engineering.
“The conferees expect the [new] arrangement or contract to be structured . . . similar to previous contracts for JASON research studies,” the NDAA conference report said.
The JASON panel is widely esteemed as a source of independent scientific expertise that is relatively free of institutional bias. Its reports are often able to provide insight into challenging technological problems of various kinds.
The FY2020 defense authorization bill calls for new JASON assessments of electronic warfare programs, and of options for replacement of the W78 warhead.
In 2019 the JASONs performed studies on Pit Aging (NNSA), Bio Threats (DOE), and Fundamental Research Security (NSF), among others.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.